Urgent in the World

Breaking news, corroborated before it is published
← All stories
DEVELOPING — SINGLE SOURCE, NOT YET CORROBORATED

Could new US investment curbs complicate China’s biotech licensing surge?

26 Oct 2026, 08:00 UTC · 1 source
Share: WhatsApp X Email

🚨 US DRAFT RULES COULD HIT CHINESE BIOTECH INVESTMENT David Zhang of Trivium China says the US Treasury Department’s draft rules would “make it much harder” for Chinese biotech firms to attract direct US investment. He says the rules could also make it harder for them to enter joint ventures. Source: South China Morning Post #US #China #biotechlicensingsurge #investmentcurbs

Sources